TolterodineHydrobromide

CAS: 837376-36-0

Ref. 3D-FT148292

Produktinformation

• Name: TolterodineHydrobromide
• Synonyme: 2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol hydrobromide, 2-[3-[Bis(1-Methylethyl)Amino]-1-Phenylpropyl]-4-Methylphenol Hydrobromide, 2-{(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl}-4-methylphenol hydrobromide, N,N-Diisopropyl-3-(2-hydroxy-5-Methylphenyl)-3-Phenylpropylamine HBr, N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine hydrobromide, N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine hydrobromide, Phenol, 2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, hydrobromide, Phenol, 2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, hydrobromide (1:1), Racemic tolterodine hydrobromide

Beschreibung

Tolterodine is a prodrug that is converted to its active form, tolterodine tartrate, by sulfonation of the diisopropylamine moiety. Tolterodine has a high affinity for the ileal and vesical muscarinic receptors and is used in the treatment of overactive bladder and urinary incontinence. The conversion of tolterodine to its active form can be inhibited by markers such as erythromycin, ketoconazole, or itraconazole. Tolterodine also has enantiomeric forms (d-tolterodine and l-tolterodine). The presence of d-tolterodine was shown to be associated with increased efficacy in patients with overactive bladder symptoms who have been treated with this drug.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 406.4 g/mol
• Formel: C₂₂H₃₂BrNO
• Reinheit: Min. 95%